ReviewCurrent cancer drug targets2021

Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL).

Yusuke Isshiki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.